A new research document with title Global Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market Report covering detailed analysis, Competitive landscape, forecast and strategies has been added to the Insight Partners. The study covers geographic analysis that includes regions like North America, Europe and Asia-Pacific, South America, Middle East and Africa. The report will help user gain market insights, future trends and growth prospects for forecast to 2028.
The SIBO diagnostics market was valued at US$ 138,324.23 thousand in 2020, and it is projected to reach US$ 194,604.51 thousand by 2028; it is expected to grow at a CAGR of 4.4% from 2021 to 2028.
Download PDF Report Sample with statistical info @ https://www.theinsightpartners.com/sample/TIPRE00020544/
Top Leading Companies
Increasing Prevalence of Irritable Bowel Syndrome (IBS) and SIBO
Irritable bowel syndrome (IBS) is the commonly diagnosed gastrointestinal disorder with abdominal pain and altered bowel habits resulting with associated symptoms such as bloating, malabsorption, and systemic symptoms. The incidences of IBS are increasing at a significant rate across the world. According to a research article, ‘Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study’ published by Elsevier Inc. in 2021, most countries have a prevalence rate of 2–6%. Countries such as Japan, China, Russia, South Africa, and the US have a prevalence rate of 2.2%, 2.3%, 5.9%, 5.9%, and 5.3%, respectively. The increasing prevalence of IBS across the world is due to the changing lifestyle and dietary habits. Small intestinal bacterial overgrowth (SIBO) is widely associated with the IBS.
Likewise, SIBO shows similar symptoms to IBS. Technological developments have now allowed the diagnosis of SIBO while diagnosing IBS. Therefore, the prevalence of SIBO is widely understood and reported worldwide. For instance, according to an article, ’Small Intestinal Bacterial Overgrowth: A Case-Based Review’ published in the Journal of Patient-Centered Research and Reviews (JPCRR) in November 2015, 30–85% of adult patients with IBS are likely to develop SIBO. Similarly, according to the recent data published in 2020 by the American College of Gastroenterology, ~78% of IBS patients are living with SBIO; hence, it is a predominantly evaluated condition. It is, therefore, estimated that the prevalence of IBS and SIBO will grow significantly in the near future, leading to the increasing diagnosis and eventual market growth.
Our expert team is consistently working on updated data and information of key player’s related business processes which values the market. For future strategies and predictions, we provide special section regarding covid-19 situation.
Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market which would mention How the Covid-19 is Affecting the Market Trends and Potential Opportunities in the COVID-19 Landscape, Covid-19 Impact on Key Regions and Proposal for Disposable Incontinence Products (DIPs) Players to fight Covid-19 Impact.
The researchers have analysed the competitive advantages of those involved in the industries or in the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics industry. While historical years were taken as 2021 – 2028, the base year for the study was 2021. Similarly, the report has given its projection for the year 2021 apart from the outlook for years 2021 – 2028.
The objective of the researchers is to find out the sales, value, and status of the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics industry at the international levels. While the status covers the years of 2021 – 2028, the forecast is for the period 2021 – 2028 that will enable market players to not only plan but also execute strategies based on the market needs.
The study wanted to focus on key manufacturers, competitive landscape, and SWOT analysis for the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market. Apart from looking into the geographical regions, the report concentrated on key trends and segments that are either driving or preventing the growth of the industry. Researchers have also focused on individual growth trends besides their contribution to the overall market.
An outline of the regional analysis:
Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics market recent innovations and major events.
Additional highlights of the Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics market report:
Note: Access insightful study with over 150+ pages, list of tables & figures, profiling 10+ companies.
Purchase This Report at: https://www.theinsightpartners.com/buy/TIPRE00020544/
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.